Combined company renamed Nuvation Bio Inc., will be listed on the New York Stock Exchange under ticker symbol "NUVB"
Strong cash position of approximately $830 million includes approximately $646 million held in Panacea's trust account and from concurrent private financings
PR Newswire
NEW YORK, Feb. 10, 2021